You have changed your country from  to  . Please be aware that this will change the currency in the purchasing process.

Overview

  • Product nameAnti-PML Protein antibodySee all PML Protein primary antibodies ...
  • Description
    Rabbit polyclonal to PML Protein
  • SpecificityThis antibody detects endogenous levels of total PML protein.
  • Tested applicationsWB, ELISA, IHC-P, ICC/IF more details
  • Species reactivity
    Reacts with: Mouse, Human
  • Immunogen

    Synthetic peptide derived from human PML protein

  • Positive controlExtracts from A549 cells

Properties

Applications

Our Abpromise guarantee covers the use of ab53773 in the following tested applications.

The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.

Application Notes
WB WB: 1/500 - 1/1000. Detects a band of approximately 100 kDa (predicted molecular weight: 69 kDa).
ELISA ELISA: 1/10000.
IHC-P IHC-P: Use a concentration of 4 µg/ml. Perform heat mediated antigen retrieval before commencing with IHC staining protocol.
ICC/IF ICC/IF: 1/100 - 1/250.

Target

  • FunctionKey component of PML nuclear bodies that regulate a large number of cellular processes by facilitating post-translational modification of target proteins, promoting protein-protein contacts, or by sequestering proteins. Functions as tumor suppressor. Required for normal, caspase-dependent apoptosis in response to DNA damage, FAS, TNF, or interferons. Plays a role in transcription regulation, DNA damage response, DNA repair and chromatin organization. Plays a role in processes regulated by retinoic acid, regulation of cell division, terminal differentiation of myeloid precursor cells and differentiation of neural progenitor cells. Required for normal immunity to microbial infections. Plays a role in antiviral response. In the cytoplasm, plays a role in TGFB1-dependent processes. Regulates p53/TP53 levels by inhibiting its ubiquitination and proteasomal degradation. Regulates activation of p53/TP53 via phosphorylation at 'Ser-20'. Sequesters MDM2 in the nucleolus after DNA damage, and thereby inhibits ubiquitination and degradation of p53/TP53. Regulates translation of HIF1A by sequestering MTOR, and thereby plays a role in neoangiogenesis and tumor vascularization. Regulates RB1 phosphorylation and activity. Required for normal development of the brain cortex during embryogenesis. Can sequester herpes virus and varicella virus proteins inside PML bodies, and thereby inhibit the formation of infectious viral particles. Regulates phosphorylation of ITPR3 and plays a role in the regulation of calcium homeostasis at the endoplasmic reticulum (By similarity). Regulates transcription activity of ELF4. Inhibits specifically the activity of the tetrameric form of PKM2. Together with SATB1, involved in local chromatin-loop remodeling and gene expression regulation at the MHC-I locus. Regulates PTEN compartmentalization through the inhibition of USP7-mediated deubiquitinylation.
  • Involvement in diseaseNote=A chromosomal aberration involving PML may be a cause of acute promyelocytic leukemia (APL). Translocation t(15;17)(q21;q21) with RARA. The PML breakpoints (type A and type B) lie on either side of an alternatively spliced exon.
  • Sequence similaritiesContains 2 B box-type zinc fingers.
    Contains 1 RING-type zinc finger.
  • DomainInteracts with PKM2 via its coiled-coil domain.
    Binds arsenic via the RING-type zinc finger.
  • Post-translational
    modifications
    Ubiquitinated; mediated by RNF4, SIAH1 or SIAH2 and leading to subsequent proteasomal degradation. 'Lys-6'-, 'Lys-11'-, 'Lys-48'- and 'Lys-63'-linked polyubiquitination by RNF4 is polysumoylation-dependent.
    Undergoes 'Lys-11'-linked sumoylation. Sumoylation on all three sites is required for nuclear body formation. Sumoylation on Lys-160 is a prerequisite for sumoylation on Lys-65. The PML-RARA fusion protein requires the coiled-coil domain for sumoylation. Desumoylated by SENP2 and SENP6. Arsenic induces PML and PML-RARA oncogenic fusion proteins polysumoylation and their subsequent RNF4-dependent ubiquitination and proteasomal degradation, and is used as treatment in acute promyelocytic leukemia (APL).
    Phosphorylated in response to DNA damage, probably by ATR.
    Acetylation may promote sumoylation and enhance induction of apoptosis.
  • Cellular localizationNucleus > nucleoplasm. Cytoplasm. Nucleus > PML body. Nucleus > nucleolus. Endoplasmic reticulum membrane. Early endosome membrane. Sumoylated forms localize to the PML nuclear bodies. The B1 box and the RING finger are also required for this nuclear localization. Isoforms lacking a nuclear localization signal are cytoplasmic. Detected in the nucleolus after DNA damage. Sequestered in the cytoplasm by interaction with rabies virus phosphoprotein.
  • Target information above from: UniProt accession P29590 The UniProt Consortium
    The Universal Protein Resource (UniProt) in 2010
    Nucleic Acids Res. 38:D142-D148 (2010) .

    Information by UniProt
  • Database links
  • Alternative names
      MYL antibodyPML antibodyPML_HUMAN antibody
      PP8675 antibodyProbable transcription factor PML antibodyPromyelocytic leukemia antibodyPromyelocytic leukemia inducer of antibodyPromyelocytic leukemia protein antibodyProtein PML antibodyRING finger protein 71 antibodyRNF 71 antibodyRNF71 antibodyTRIM 19 antibodyTRIM19 antibodyTripartite motif containing protein 19 antibodyTripartite motif protein TRIM19 antibodyTripartite motif-containing protein 19 antibody
    see all

Anti-PML Protein antibody images

  • All lanes : Anti-PML Protein antibody (ab53773) at 1/500 dilution

    Lane 1 : Extracts from A549 cells
    Lane 2 : Extracts from A549 cells, plus immunising peptide


    Predicted band size : 69 kDa
    Observed band size : 100 kDa (why is the actual band size different from the predicted?)
  • ab53773 (1/200) staining PML protein in Hela cells (green). Cells were fixed with methanol, permeabilised with triton X-100/PBS and counterstained with DAPI in order to highlight the nucleus (red). Please refer to abreview for further experimental details.

    See Abreview

  • Ab53773 staining Human normal colon. Staining is localized to the nucleus.
    Left panel: with primary antibody at 4 ug/ml. Right panel: isotype control.
    Sections were stained using an automated system DAKO Autostainer Plus , at room temperature. Sections were rehydrated and antigen retrieved with the Dako 3-in-1 AR buffer EDTA pH 9.0 in a DAKO PT Link. Slides were peroxidase blocked in 3% H2O2 in methanol for 10 minutes. They were then blocked with Dako Protein block for 10 minutes (containing casein 0.25% in PBS), then incubated with primary antibody for 20 minutes, and detected with Dako Envision Flex amplification kit for 30 minutes. Colorimetric detection was completed with diaminobenzidine for 5 minutes. Slides were counterstained with Haematoxylin and coverslipped under DePeX. Please note that for manual staining we recommend to optimize the primary antibody concentration and incubation time (overnight incubation), and amplification may be required.

References for Anti-PML Protein antibody (ab53773)

This product has been referenced in:

See all 6 Publications for this product

Product Wall

Filter by Application

Filter by Species

Filter by Ratings

Application Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections)
Sample Rat Tissue sections (Ovary)
Specification Ovary
Fixative Paraformaldehyde
Antigen retrieval step Heat mediated - Buffer/Enzyme Used: Tris-EDTA pH 9.0
Permeabilization No
Blocking step Serum as blocking agent for 1 hour(s) and 0 minute(s) · Concentration: 4% · Temperature: RT°C
Username

Verified customer

Submitted Jul 19 2012

Application Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections)
Sample Mouse Tissue sections (Testis)
Specification Testis
Fixative Paraformaldehyde
Antigen retrieval step Heat mediated - Buffer/Enzyme Used: Tris-EDTA pH 9.0
Permeabilization No
Blocking step Serum as blocking agent for 1 hour(s) and 0 minute(s) · Concentration: 4% · Temperature: RT°C
Username

Verified customer

Submitted Jul 19 2012

Application Immunocytochemistry/ Immunofluorescence
Sample Human Cell (U2OS human osteosarcoma cell line)
Specification U2OS human osteosarcoma cell line
Fixative Formaldehyde
Permeabilization Yes - triton 0,5% in PBS for 5 min
Blocking step Serum as blocking agent for 1 hour(s) and 0 minute(s) · Concentration: 10% · Temperature: RT°C
Username

Verified customer

Submitted Jan 20 2012

Application Immunocytochemistry/ Immunofluorescence
Sample Human Cell (WI38 human fibroblasts)
Specification WI38 human fibroblasts
Fixative Formaldehyde
Permeabilization Yes - triton 0,5% 5min
Blocking step Serum as blocking agent for 1 hour(s) and 0 minute(s) · Concentration: 10% · Temperature: RT°C
Username

Verified customer

Submitted Jan 19 2012

Application Immunocytochemistry/ Immunofluorescence
Sample Human Cell (Jurkat)
Specification Jurkat
Fixative Paraformaldehyde
Permeabilization Yes - 0.2% Triton X-100 in PBS
Username

Verified customer

Submitted Dec 29 2010

Application Immunocytochemistry/ Immunofluorescence
Sample Human Cell (Fibroblasts)
Specification Fibroblasts
Fixative Paraformaldehyde
Permeabilization Yes - Methanol, 30 min at -20°C
Blocking step FCS as blocking agent for 30 minute(s) · Concentration: 20% · Temperature: RT°C
Username

Verified customer

Submitted Dec 10 2010

Application Immunocytochemistry/ Immunofluorescence
Sample Human Cell (HaCaT keratinocyte)
Specification HaCaT keratinocyte
Fixative Paraformaldehyde
Permeabilization Yes - 0.25% triton X-100
Blocking step 2.5% BSA plus 1% goat serum as blocking agent for 1 hour(s) and 0 minute(s) · Concentration: 2.5% · Temperature: 24°C
Username

Verified customer

Submitted Jun 05 2009

Application Immunocytochemistry/ Immunofluorescence
Sample Mouse Cell (Embryonic Skin, epidermal keratinocyets,)
Specification Embryonic Skin, epidermal keratinocyets,
Fixative Formaldehyde
Permeabilization Yes - 1%TritonX-100/0.2%Saponin
Username

Verified customer

Submitted Aug 15 2008

Application Immunocytochemistry/ Immunofluorescence
Sample Human Cell (HeLa)
Specification HeLa
Fixative Methanol
Permeabilization Yes - 0.5% TritonX100 in PBS
Username

Verified customer

Submitted Nov 09 2007

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"